Barclays
IBB icon

Barclays’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$49.4M Sell
390,159
-330,506
-46% -$41.8M 0.01% 528
2025
Q1
$92.2M Buy
720,665
+41,948
+6% +$5.37M 0.03% 348
2024
Q4
$89.7M Buy
678,717
+321,632
+90% +$42.5M 0.03% 322
2024
Q3
$52M Buy
357,085
+315,994
+769% +$46M 0.01% 493
2024
Q2
$5.64M Buy
41,091
+39,155
+2,022% +$5.37M ﹤0.01% 1118
2024
Q1
$266K Sell
1,936
-1,461
-43% -$201K ﹤0.01% 3193
2023
Q4
$461K Sell
3,397
-16,383
-83% -$2.22M ﹤0.01% 3042
2023
Q3
$2.42M Sell
19,780
-114,105
-85% -$14M ﹤0.01% 1548
2023
Q2
$17M Sell
133,885
-18,156
-12% -$2.31M 0.01% 728
2023
Q1
$19.6M Buy
152,041
+149,413
+5,685% +$19.3M 0.01% 599
2022
Q4
$346K Sell
2,628
-389,005
-99% -$51.2M ﹤0.01% 2804
2022
Q3
$45.8M Buy
391,633
+263,247
+205% +$30.8M 0.05% 331
2022
Q2
$15.1M Sell
128,386
-179,287
-58% -$21.1M 0.01% 679
2022
Q1
$40.1M Sell
307,673
-8,092
-3% -$1.05M 0.03% 462
2021
Q4
$48.2M Sell
315,765
-1,311,052
-81% -$200M 0.02% 435
2021
Q3
$263M Buy
1,626,817
+235,319
+17% +$38M 0.12% 105
2021
Q2
$228M Buy
1,391,498
+183,946
+15% +$30.1M 0.11% 117
2021
Q1
$182M Sell
1,207,552
-152,571
-11% -$23M 0.1% 126
2020
Q4
$206M Sell
1,360,123
-699,484
-34% -$106M 0.11% 90
2020
Q3
$279M Sell
2,059,607
-542,762
-21% -$73.5M 0.17% 67
2020
Q2
$356M Sell
2,602,369
-461,471
-15% -$63.1M 0.27% 28
2020
Q1
$330M Sell
3,063,840
-54,913
-2% -$5.92M 0.26% 27
2019
Q4
$376M Sell
3,118,753
-50,876
-2% -$6.13M 0.21% 40
2019
Q3
$315M Buy
3,169,629
+3,011,766
+1,908% +$300M 0.2% 50
2019
Q2
$17.2M Sell
157,863
-19,080
-11% -$2.08M 0.01% 647
2019
Q1
$19.8M Buy
176,943
+126,261
+249% +$14.1M 0.01% 546
2018
Q4
$4.89M Buy
50,682
+30,951
+157% +$2.98M ﹤0.01% 947
2018
Q3
$2.41M Sell
19,731
-14,339
-42% -$1.75M ﹤0.01% 1633
2018
Q2
$3.74M Sell
34,070
-191,637
-85% -$21M ﹤0.01% 1098
2018
Q1
$24.1M Buy
225,707
+83,460
+59% +$8.91M 0.02% 509
2017
Q4
$15.2M Buy
142,247
+101,052
+245% +$10.8M 0.01% 574
2017
Q3
$13.7M Sell
41,195
-89,417
-68% -$29.8M 0.01% 479
2017
Q2
$40.5M Sell
130,612
-191,192
-59% -$59.3M 0.04% 207
2017
Q1
$94.4M Buy
321,804
+139,820
+77% +$41M 0.1% 91
2016
Q4
$48.3M Buy
181,984
+11,547
+7% +$3.06M 0.05% 155
2016
Q3
$49.3M Buy
170,437
+28,910
+20% +$8.37M 0.05% 138
2016
Q2
$36.4M Buy
141,527
+17,500
+14% +$4.5M 0.05% 182
2016
Q1
$32.2M Buy
124,027
+87,192
+237% +$22.7M 0.05% 200
2015
Q4
$12.5M Sell
36,835
-178,187
-83% -$60.2M 0.02% 409
2015
Q3
$65.2M Buy
215,022
+212,462
+8,299% +$64.4M 0.08% 104
2015
Q2
$942K Buy
2,560
+2,500
+4,167% +$920K ﹤0.01% 1513
2015
Q1
$21K Sell
60
-298,320
-100% -$104M ﹤0.01% 3086
2014
Q4
$90.4M Sell
298,380
-491,215
-62% -$149M 0.09% 98
2014
Q3
$216M Buy
789,595
+48,954
+7% +$13.4M 0.21% 39
2014
Q2
$190M Sell
740,641
-292,182
-28% -$75.1M 0.2% 40
2014
Q1
$244M Buy
1,032,823
+414,834
+67% +$97.9M 0.28% 31
2013
Q4
$140M Sell
617,989
-80,181
-11% -$18.2M 0.14% 64
2013
Q3
$146M Buy
698,170
+30,085
+5% +$6.29M 0.17% 45
2013
Q2
$116M Buy
+668,085
New +$116M 0.14% 55